scPharmaceuticals to Announce First Quarter 2023 Financial Results on Wednesday, May 10, 2023

Rhea-AI Summary

scPharmaceuticals Inc. to host conference call and webcast to discuss financial results for Q1 2023 and provide business update.

Positive

• scPharmaceuticals management will host a conference call and webcast to discuss the financial results for the first quarter 2023 and provide a business update.

Negative

• None.

Management to host conference call and webcast at 4:30 p.m. ET

BURLINGTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, May 10, 2023, to discuss the financial results for the first quarter 2023 and provide a business update.

Participants should dial 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13737717.

To access the new Call me™ feature, which avoids having to wait for an operator, click here.

The live webcast and replay of the conference call can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
PJ Kelleher
LifeSci Advisors, 617-430-7578
pkelleher@lifesciadvisors.com

FAQ

What is the purpose of the conference call and webcast?

The conference call and webcast are being held to discuss the financial results for the first quarter 2023 and provide a business update.

When will the conference call and webcast take place?

The conference call and webcast will take place at 4:30 p.m. ET on Wednesday, May 10, 2023.

How can participants access the conference call and webcast?

Participants can dial 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13737717. The webcast can be accessed on the company's website, www.scpharmaceuticals.com.

Is there a replay available for the conference call?

Yes, a replay of the conference call will be available on the company's website after the event.